3B BlackBio DX Intrinsic Value
3B BlackBio DX intrinsic value. 3B BlackBio DX (3BBLACKBIO) median intrinsic value is ₹549.12 from 10 valuation models (range ₹360–₹812), vs current price ₹1624.70 — -66.2% downside (Trading Above Calculated Value), margin of safety -100.0%. Compare with 3BBLACKBIO DCF valuation to assess whether the stock is under or overvalued.
3BBLACKBIO Valuation Methods Summary — DCF, Graham Number & P/E
3B BlackBio DX intrinsic value across 10 models vs current price ₹1624.70 — upside/downside and value range per method. Read 3BBLACKBIO dividend history for the complete payout history and dividend yield track record.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹549.12 | ₹439.30 - ₹658.94 | -66.2% | EPS: ₹45.76, Sector P/E: 12x |
| Book Value Method | asset | ₹360.00 | ₹324.00 - ₹396.00 | -77.8% | Book Value/Share: ₹360.00, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹487.41 | ₹438.67 - ₹536.15 | -70.0% | Revenue/Share: ₹204.44, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹649.88 | ₹584.89 - ₹714.87 | -60.0% | EBITDA: ₹76.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹649.88 | ₹519.90 - ₹779.86 | -60.0% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹487.41 | ₹438.67 - ₹536.15 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹487.41 | ₹438.67 - ₹536.15 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹812.35 | ₹731.12 - ₹893.59 | -50.0% | ROE: 12.3%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹608.82 | ₹547.94 - ₹669.70 | -62.5% | EPS: ₹45.76, BVPS: ₹360.00 |
| Dividend Yield Method | dividend | ₹487.41 | ₹438.67 - ₹536.15 | -70.0% | DPS: ₹5.00, Target Yield: 3.5% |
3BBLACKBIO Intrinsic Value vs Market Price — All Valuation Models
3B BlackBio DX fair value range ₹360–₹812 vs current market price ₹1624.70 across 10 valuation models. For current market price and key ratios, visit 3B BlackBio DX screener.
3BBLACKBIO Intrinsic Value Analysis — Undervalued or Overvalued?
3B BlackBio DX median intrinsic value ₹549.12, current price ₹1624.70 — Trading Above Calculated Value by 66.2%, margin of safety -100.0%.
What is the intrinsic value of 3BBLACKBIO?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of 3B BlackBio DX (3BBLACKBIO) is ₹549.12 (median value). With the current market price of ₹1624.70, this represents a -66.2% variance from our estimated fair value.
The valuation range spans from ₹360.00 to ₹812.35, indicating ₹360.00 - ₹812.35.
Is 3BBLACKBIO undervalued or overvalued?
Based on our multi-method analysis, 3B BlackBio DX (3BBLACKBIO) appears to be trading above calculated value by approximately 66.2%.
3BBLACKBIO Financial Health — Key Ratios vs Industry Benchmarks
3B BlackBio DX financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 19.30 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 12.3% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 24.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.49x | Industry Standard: 1.0x+ | Below 0.5x | Measures asset utilization efficiency |
3BBLACKBIO Cash Flow Quality — Operating & Free Cash Flow
3B BlackBio DX operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹43 Cr | ₹26 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹27 Cr | ₹17 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹20 Cr | ₹20 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹37 Cr | ₹23 Cr | Positive Free Cash Flow | 8/10 |
| March 2021 | ₹98 Cr | ₹63 Cr | Positive Free Cash Flow | 8/10 |